NCT00004062View on ClinicalTrials.gov

Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Study Completion Date

August 31, 2006

Conditions
Head and Neck Cancer
Interventions
DRUG

azacitidine

DRUG

liothyronine sodium

RADIATION

iodine I 131

Trial Locations (1)

40536-0084

Albert B. Chandler Medical Center, University of Kentucky, Lexington

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Lucille P. Markey Cancer Center at University of Kentucky

OTHER

NCT00004062 - Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer | Biotech Hunter | Biotech Hunter